Skip to main content
رجوع
Watch Compare

Cannabis Bioscience International Holdings, Inc.

جودة البيانات: 100%
CBIH
OTC Services Engineering & Management Services
KWD 0.00
▲ KWD 0.00 (25.00%)
القيمة السوقية: 5.81 M
السعر
KWD 0.00
القيمة السوقية
5.81 M
نطاق اليوم
KWD 0.00 — KWD 0.00
نطاق 52 أسبوعًا
KWD 0.00 — KWD 0.00
حجم التداول
12,000
فتح KWD 0.00
متوسط 50 يوم / 200 يوم
KWD 0.00
25.00% above
متوسط 50 يوم / 200 يوم
KWD 0.00
0.00% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -408,419.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)21.77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-333.39%
Op. Margin-245.25%

الأمان

Debt / Equity
N/A
Current Ratio0.02
Interest Coverage-2.92

التقييم

PE (TTM)
-8.65
أقل من متوسط القطاع (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Services (502 نظير)
المقياس السهم وسيط القطاع
P/E -8.7 -1.2
P/B — 1.4
ROE % — -16.0
Net Margin % -333.4 -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2026 — 369,000.01 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 21.77% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 201,601.0 Net Income (TTM) -672,127.0
ROE N/A ROA -3272.84%
Gross Margin 75.01% Operating Margin -245.25%
Net Margin -333.39% Free Cash Flow (TTM) -408,419.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.02
Interest Coverage -2.92 Asset Turnover 9.82
Working Capital -1.11 M Tangible Book Value -1.36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8.65 Forward P/E N/A
P/B Ratio N/A P/S Ratio 28.84
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7.03%
Market Cap 5.81 M Enterprise Value 6.10 M
Per Share
EPS (Diluted TTM) 0.00 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 60.77%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 303,022.0 248,841.0
Net Income -548,820.0 -651,345.0
EPS (Diluted) 0.00 0.00
Gross Profit 262,916.0 203,242.0
Operating Income -421,365.0 -486,140.0
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A — —
Interest Expense 136,262.0 154,206.0
Income Tax — 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 31,880.0 57,162.0
Total Liabilities 1.20 M 1.14 M
Shareholders' Equity -1.16 M -1.08 M
Total Debt 286,187.0 256,415.0
Cash & Equivalents — —
Current Assets 29,085.0 21,492.0
Current Liabilities 945,963.0 881,908.0